XML 53 R42.htm IDEA: XBRL DOCUMENT v3.25.3
Stock Options - SARs (Details) - Stock Appreciation Rights (SARs) - USD ($)
3 Months Ended 9 Months Ended
Apr. 18, 2022
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Dec. 31, 2024
SARs            
Outstanding beginning balance       456,702    
Exercised       (8,048)    
Forfeited       (14,125)    
Outstanding ending balance   434,529   434,529    
SARs fully vested and exercisable   63,779   63,779    
Weighted average exercise price            
Weighted average exercise price, beginning balance (per share)       $ 39.61    
Weighted average exercise price, exercised (per share)       39.33    
Weighted average exercise price, forfeited (per share)       39.33    
Weighted average exercise price, ending balance (per share)   $ 39.62   39.62    
SARs Weighted average exercise price       $ 39.34    
Aggregate intrinsic value            
Aggregate intrinsic value   $ 12,657,000   $ 12,657,000    
SAR Aggregate intrinsic value   1,876,000   $ 1,876,000    
Weighted average remaining contractual term (years)       6 years 9 months 14 days    
SAR Weighted average remaining contractual term (years)       6 years 9 months    
Fair Value of Liability   6,313,000   $ 6,313,000   $ 4,540,000
Stock-based compensation expense   758,000 $ 847,000 2,020,000 $ 2,271,000  
Stock-based compensation cost, unrecognized   $ 7,754,000   $ 7,754,000    
Stock-based compensation cost, unrecognized, weighted-average period of recognition       6 years 9 months 18 days    
SAR Plan            
Stock option details            
Shares available for future grants 750,000          
Maximum exercisable period for granted share-based compensation 10 years          
Number of rights issued       434,529    
Vesting period 8 years          
SARs            
Granted       434,529